XML 25 R14.htm IDEA: XBRL DOCUMENT v3.10.0.1
Net Income Attributable to Inter Parfums, Inc. Common Shareholders
9 Months Ended
Sep. 30, 2018
Earnings Per Share [Abstract]  
Net Income Attributable to Inter Parfums, Inc. Common Shareholders
7. Net Income Attributable to Inter Parfums, Inc. Common Shareholders:

 

Net income attributable to Inter Parfums, Inc. per common share (“basic EPS”) is computed by dividing net income attributable to Inter Parfums, Inc. by the weighted average number of shares outstanding. Net income attributable to Inter Parfums, Inc. per share assuming dilution (“diluted EPS”), is computed using the weighted average number of shares outstanding, plus the incremental shares outstanding assuming the exercise of dilutive stock options using the treasury stock method.

 

The reconciliation between the numerators and denominators of the basic and diluted EPS computations is as follows:

 

(In thousands)   Three months ended
September 30,
    Nine months ended
September 30,
 
    2018     2017     2018     2017  
Numerator:                        
Net income attributable to Inter Parfums, Inc.   $ 18,938     $ 17,077     $ 45,746     $ 37,194  
Denominator:                                
Weighted average shares     31,326       31,175       31,297       31,163  
Effect of dilutive securities:                                
Stock options     261       132       205       118  
Denominator for diluted earnings per share     31,587       31,307       31,502       31,281  
                                 
Earnings per share:                                
Net income attributable to Inter Parfums, Inc. common shareholders:                                
Basic   $ 0.60     $ 0.55     $ 1.46     $ 1.19  
Diluted     0.60       0.55       1.45       1.19  

 

Not included in the above computations is the effect of antidilutive potential common shares which consist of outstanding options to purchase 0.12 million shares of common stock for the nine months ended September 30, 2018, as compared to 0.22 million shares and 0.31 million shares of common stock for the three and nine months ended September 30, 2017, respectively. There were no antidilutive potential common shares for the three months ended September 30, 2018.